Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients

OBJECTIVE: Patients with FIGO stage III endometrial cancer routinely receive adjuvant therapy. The purpose of this study was to evaluate overall survival (OS) and disease-free survival (DFS) in patients with stage IIIA to IIIC2 patients by treatment modality received and risk factors. MATERIALS/METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Nora, Kumar, Aalok, Gelowitz, Gerald, Tinker, Anna, Holloway, Caroline, Ko, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117830/
https://www.ncbi.nlm.nih.gov/pubmed/37091159
http://dx.doi.org/10.3389/fonc.2023.1035511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117830/
https://www.ncbi.nlm.nih.gov/pubmed/37091159
http://dx.doi.org/10.3389/fonc.2023.1035511

Ejemplares similares